Open Access

[Corrigendum] RNA‑binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1

  • Authors:
    • Limin Zhou
    • Xiju Xie
  • View Affiliations

  • Published online on: January 27, 2022     https://doi.org/10.3892/etm.2022.11170
  • Article Number: 245
  • Copyright : © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

March-2022
Volume 23 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou L and Xie X: [Corrigendum] RNA‑binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1. Exp Ther Med 23: 245, 2022.
APA
Zhou, L., & Xie, X. (2022). [Corrigendum] RNA‑binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1. Experimental and Therapeutic Medicine, 23, 245. https://doi.org/10.3892/etm.2022.11170
MLA
Zhou, L., Xie, X."[Corrigendum] RNA‑binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1". Experimental and Therapeutic Medicine 23.3 (2022): 245.
Chicago
Zhou, L., Xie, X."[Corrigendum] RNA‑binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1". Experimental and Therapeutic Medicine 23, no. 3 (2022): 245. https://doi.org/10.3892/etm.2022.11170